about
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...
Read More
2.55
-0.08
(-3.04%)
25,726.7
XNAS Volume
XNAS 13 Mar, 2026 10:45 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Genelux Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..